CHARLES SCHWAB INVESTMENT MANAGEMENT INC - ARCUS BIOSCIENCES INC ownership

ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of ARCUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$8,272,096
-6.7%
460,841
+5.5%
0.00%
-33.3%
Q2 2023$8,870,209
+15.3%
436,741
+3.6%
0.00%
+50.0%
Q1 2023$7,691,644
-4.3%
421,691
+8.5%
0.00%
-33.3%
Q4 2022$8,038,729
-18.9%
388,720
+2.5%
0.00%
-25.0%
Q3 2022$9,917,000
+14.0%
379,094
+10.4%
0.00%
+33.3%
Q2 2022$8,699,000
-16.6%
343,281
+3.8%
0.00%0.0%
Q1 2022$10,436,000
-20.0%
330,651
+2.6%
0.00%
-25.0%
Q4 2021$13,038,000
+5.2%
322,150
-9.3%
0.00%0.0%
Q3 2021$12,388,000
+30.9%
355,241
+3.1%
0.00%
+33.3%
Q2 2021$9,462,000
+1.1%
344,559
+3.4%
0.00%0.0%
Q1 2021$9,359,000
+25.6%
333,271
+16.1%
0.00%0.0%
Q4 2020$7,453,000
+53.6%
287,080
+1.5%
0.00%
+50.0%
Q3 2020$4,851,000
-23.5%
282,973
+10.4%
0.00%
-33.3%
Q2 2020$6,340,000
+132.7%
256,253
+30.6%
0.00%
+50.0%
Q1 2020$2,724,000
+40.6%
196,241
+2.3%
0.00%
+100.0%
Q4 2019$1,937,000
+12.2%
191,763
+1.1%
0.00%0.0%
Q3 2019$1,727,000
+123.4%
189,685
+95.3%
0.00%
Q2 2019$773,000
-37.4%
97,127
-1.6%
0.00%
-100.0%
Q1 2019$1,234,000
+22.1%
98,736
+5.2%
0.00%0.0%
Q4 2018$1,011,000
+42.8%
93,839
+84.9%
0.00%
Q3 2018$708,000
+44.2%
50,747
+26.7%
0.00%
Q2 2018$491,00040,0410.00%
Other shareholders
ARCUS BIOSCIENCES INC shareholders Q4 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 1,612,077$50,877,00022.64%
Octagon Capital Advisors LP 2,489,974$78,584,00016.99%
Decheng Capital Management III (Cayman), LLC 869,790$27,451,0008.41%
BVF INC/IL 3,960,948$125,008,0005.00%
PFM Health Sciences, LP 3,431,010$108,283,0004.05%
EcoR1 Capital, LLC 3,265,101$103,047,0003.22%
Alphabet Inc. 2,563,441$80,902,0002.62%
Boxer Capital, LLC 1,432,200$45,200,0002.32%
SECTORAL ASSET MANAGEMENT INC 338,480$10,682,0001.90%
PARK CIRCLE Co 64,000$2,020,0001.68%
View complete list of ARCUS BIOSCIENCES INC shareholders